Learn More
Cayman Chemical GYKI 52466hydrochlorIde 50mg

Supplier: Cayman Chemical 3441850 MG
An allosteric AMPA receptor antagonist; selectively inhibits AMPA-induced inward currents (IC50 = 7.5 µM) over NMDA- or GABA-induced inward currents in primary rat hippocampal neurons at 50 µM but also inhibits kainate-induced inward currents in the same cells (IC50 = 11 µM); reduces the amplitude of spontaneous EPSCs in the same cells at 10 µM; increases the latency to seizure onset and reduces mortality in a rat model of 4-AP-induced generalized tonic-clonic seizures at 25 and 50 mg/kg; prevents neuronal damage in the CA1 region of the hippocampus in a four-vessel occlusion-induced rat model of global ischemia-reperfusion injury at 30 mg/kg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.